Recently a new drug for treatment of Hepatitis C has been discovered by a US based pharmaceutical company Gilead Sciences. The drug is "SOVALDI" and costs 50000 for one tab. We had a discussion about this drug about two months ago ( Availability Of Sovaldi In Delhi ) This is a one though provoking article on cost-benefit analysis of expensive medicine that exclusively talks about Sovaldi. Author Michael Kirsch is a gastroenterologist who blogs at MD Whistleblower .
One catch phrase in health care reform is cost-effectiveness. To paraphrase, this label means that a medical treatment is worth the price. For example, influenza vaccine, or flu shot, is effective in reducing the risk of influenza infection. If the price of each vaccine were $1,000, it would still be medically effective, but it would no longer be cost-effective considering that over 100 million Americans need the…
